Achieve Life Sciences Inc (ACHV) Actualités

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 3 - Initial statement of beneficial ownership of securities

Form 8-K - Current report

Achieve Life Sciences Appoints Mark Oki as Chief Financial Officer

SEATTLE and VANCOUVER, British Columbia, Dec. 09, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc...

Form S-8 - Securities to be offered to employees in employee benefit plans

Achieve Life Sciences to Advance First Vaping Cessation Therapy After Successful End-of-Phase 2 Meeting with FDA

SEATTLE and VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc...

Form EFFECT - Notice of Effectiveness

Achieve Life Sciences Announces Participation at Upcoming Investor Conferences

SEATTLE and VANCOUVER, British Columbia, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc...

Form S-3 - Registration statement under Securities Act of 1933

Form POS AM - Post-Effective amendments for registration statement

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Achieve Life Sciences Reports Financial Results for Third Quarter 2024 and Provides Corporate Update

SEATTLE and VANCOUVER, British Columbia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc...

Form SC 13G - Statement of Beneficial Ownership by Certain Investors